Rapport Therapeutics

Rapport Therapeutics is dedicated to revolutionizing the treatment of neurological disorders through a precision medicine approach. By precisely targeting disease-driving neurocircuits, Rapport Therapeutics overcomes the limitations of traditional neuromedicines, which often act indiscriminately throughout the nervous system, leading to suboptimal efficacy and side effects. Rapport Therapeutics is committed to developing innovative therapies that address the complex challenges of brain disorders.

With headquarters in Boston, Massachusetts, and a significant presence in San Diego, California, Rapport Therapeutics is strategically positioned to advance its research and development efforts. The company’s approach leverages receptor-associated proteins (RAPs) to achieve targeted and effective therapeutic interventions. Rapport Therapeutics is at the forefront of neuroscience innovation, driving progress in the field of precision medicine.

Rapport Therapeutics was created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC). Rapport Therapeutics is focused on improving patient outcomes and transforming the landscape of neurological disease treatment. We invite the manager of Rapport Therapeutics to create a customized and exclusive company showcase and product listing on our platform.